University of Baltimore, Maryland
Patent Applications and Registrations
Patent applications and USPTO patent grants for University of Baltimore, Maryland.The latest application filed is for "doxorubicin containing nanoplexes and uses thereof".
- University of Baltimore, Maryland - Baltimore MD
| Patent | Date |
|---|---|
| Doxorubicin Containing Nanoplexes and Uses Thereof App 20220175958 - James; Mixson Archibald | 2022-06-09 |
| Method for Treating a Cancer Based on Inflammatory Subtype Thereof App 20220018844 - Younis; Rania H. | 2022-01-20 |
| Protein Translation Inhibitors and Uses Thereof App 20200368208 - Carrier; France ; et al. | 2020-11-26 |
| Method for Predicting Pain Sensitivity App 20200253540 - Kind Code | 2020-08-13 |
| Methods of Treating Resistant Cancers App 20200147047 - Eckert; Richard L. ; et al. | 2020-05-14 |
| Techniques for producing an image of radioactive emissions using a compton camera Grant 10,502,845 - Polf , et al. Dec | 2019-12-10 |
| Methods for Treating Bone-Related Disorders App 20190351055 - Stains; Joseph ; et al. | 2019-11-21 |
| Techniques for Producing an Image of Radioactive Emissions Using a Compton Camera App 20180188392 - Polf; Jerimy ; et al. | 2018-07-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 